Coronary Endothelial Vasomotor Function and Vascular Remodeling in Heart Transplant Recipients Randomized for Tacrolimus or Cyclosporine Immunosuppression
- 1 April 2006
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 47 (8), 1622-1629
- https://doi.org/10.1016/j.jacc.2005.10.073
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Tacrolimus or Cyclosporine: Which Is the Better Partner for Mycophenolate Mofetil in Heart Transplant Recipients?Transplantation, 2004
- Calcineurin inhibitors in heart transplantationThe Journal of Heart and Lung Transplantation, 2004
- Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant RecipientsNew England Journal of Medicine, 2003
- Role of endothelin-1 in microvascular dysfunction caused by cyclosporin aJournal of the American College of Surgeons, 2003
- Effects of the combination of rapamycin with tacrolimus or cyclosporin on experimental intimal hyperplasiaBritish Journal of Surgery, 2002
- Coronary Artery Disease in the Transplanted HeartAnnual Review of Medicine, 2000
- Comparison of the effect of rapamycin and FK506 on release of prostacyclin and endothelin in vitroClinical Biochemistry, 1993
- Endothelial and Vascular Smooth Muscle Function After Chronic Treatment with Cyclosporin AJournal of Cardiovascular Pharmacology, 1993
- Effects of successful cardiac transplantation on plasma endothelinThe American Journal of Cardiology, 1993
- Intravascular ultrasound imaging of coronary arteries. Is three layers the norm?Circulation, 1992